BusinessCURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for TuberculosisBy Nasdaq OMXAug 22, 2017, 3:19 PM UTC
BusinessAbeona Therapeutics to Host Gene Therapy R&D Day on October 11, 2017By Nasdaq OMXAug 17, 2017, 1:15 PM UTC
BusinessRAPS Publishes 10th Edition of Essential Text on US Regulatory Affairs, Plus Sector-Specific Books on Medical Devices and BiopharmaceuticalsBy Nasdaq OMXAug 16, 2017, 4:35 PM UTC
BusinessOnconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2017 Financial ResultsBy Nasdaq OMXAug 15, 2017, 11:00 AM UTC
BusinessAnthera Pharmaceuticals Provides Business Update and Reports 2017 Second Quarter Financial ResultsBy Nasdaq OMXAug 9, 2017, 12:30 PM UTC
BusinessFate Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare ConferenceBy Nasdaq OMXAug 9, 2017, 12:00 PM UTC
BusinessTaconic Biosciences Announces Partnership With Cergentis B.V. to Provide Transgene Mapping ServicesBy Nasdaq OMXAug 8, 2017, 8:44 PM UTC
BusinessInvivoscribe® Releases LeukoStrat® CDx FLT3 Mutation Assay as CE-marked IVD Assay KitBy Nasdaq OMXAug 1, 2017, 10:00 AM UTC
